
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145830410.1021/acsomega.8b03183Addition/CorrectionIn Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin
Conjugate for the Treatment of Renal Cell Carcinoma Cazzamalli Samuele Figueras Eduard Pethő Lilla Borbély Adina Steinkühler Christian Neri Dario *Sewald Norbert *05 12 2018 31 12 2018 3 12 16743 16743 14 11 2018 Copyright © 2018 American Chemical
Society2018American Chemical
SocietyThis is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.ACS Omega2018, 3 (11), 14726−14731. DOI: 10.1021/acsomega.8b02350document-id-old-9ao8b03183document-id-new-14ao-2018-031834ccc-price
==== Body
Corrigendum to Figure 3.

Figure 3 In vitro toxicity of cryptophycin-55 glycinate
(unconjugated drug) and compound 7 on SKRC-52 tumor cells.

